Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

CardioComm Solutions

DB:OUGA
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
OUGA
DB
CA$4M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The last earnings update was 122 days ago. More info.


Add to Portfolio Compare Print
  • CardioComm Solutions has significant price volatility in the past 3 months.
OUGA Share Price and Events
7 Day Returns
-28.6%
DB:OUGA
4.1%
DE Healthcare Services
7.3%
DE Market
1 Year Returns
-60%
DB:OUGA
0.9%
DE Healthcare Services
-17.7%
DE Market
OUGA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
CardioComm Solutions (OUGA) -28.6% -28.6% -9.1% -60% - -
DE Healthcare Services 4.1% -8.3% -18.1% 0.9% 24.9% 85.3%
DE Market 7.3% -17.9% -25.8% -17.7% -25.6% -29%
1 Year Return vs Industry and Market
  • OUGA underperformed the Healthcare Services industry which returned 0.9% over the past year.
  • OUGA underperformed the Market in Germany which returned -17.7% over the past year.
Price Volatility
OUGA
Industry
5yr Volatility vs Market

OUGA Value

 Is CardioComm Solutions undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether CardioComm Solutions is trading at an attractive price based on the cash flow it is expected to produce in the future. But as CardioComm Solutions has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for CardioComm Solutions. This is due to cash flow or dividend data being unavailable. The share price is €0.02.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for CardioComm Solutions's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are CardioComm Solutions's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:OUGA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$0.00
TSXV:EKG Share Price ** TSXV (2020-03-30) in CAD CA$0.03
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.1x
Germany Market PE Ratio Median Figure of 400 Publicly-Listed Companies 16.36x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of CardioComm Solutions.

DB:OUGA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:EKG Share Price ÷ EPS (both in CAD)

= 0.03 ÷ 0.00

-6.97x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CardioComm Solutions is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • CardioComm Solutions is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does CardioComm Solutions's expected growth come at a high price?
Raw Data
DB:OUGA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.97x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.29x
Germany Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for CardioComm Solutions, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on CardioComm Solutions's assets?
Raw Data
DB:OUGA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.00
TSXV:EKG Share Price * TSXV (2020-03-30) in CAD CA$0.03
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.88x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.43x
DB:OUGA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:EKG Share Price ÷ Book Value per Share (both in CAD)

= 0.03 ÷ 0.00

-17.65x

* Primary Listing of CardioComm Solutions.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CardioComm Solutions has negative assets, we can't compare the value of its assets to the DE Healthcare Services industry average.

Next steps:

  1. Take a look at our analysis of OUGA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through CardioComm Solutions's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Healthcare Services industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess CardioComm Solutions's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. CardioComm Solutions has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

OUGA Future Performance

 How is CardioComm Solutions expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CardioComm Solutions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28.6%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is CardioComm Solutions expected to grow at an attractive rate?
  • Unable to compare CardioComm Solutions's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare CardioComm Solutions's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare CardioComm Solutions's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:OUGA Future Growth Rates Data Sources
Data Point Source Value (per year)
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:OUGA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:OUGA Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 1 0 -1
2019-06-30 1 0 -1
2019-03-31 1 0 -1
2018-12-31 1 0 -1
2018-09-30 1 0 0
2018-06-30 1 0 0
2018-03-31 2 0 0
2017-12-31 2 0 0
2017-09-30 2 0 0
2017-06-30 2 0 0
2017-03-31 2 0 0
2016-12-31 2 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if CardioComm Solutions is high growth as no earnings estimate data is available.
  • Unable to determine if CardioComm Solutions is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:OUGA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from CardioComm Solutions Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:OUGA Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 0.00
2019-06-30 0.00
2019-03-31 0.00
2018-12-31 0.00
2018-09-30 0.00
2018-06-30 0.00
2018-03-31 0.00
2017-12-31 0.00
2017-09-30 0.00
2017-06-30 0.00
2017-03-31 0.00
2016-12-31 0.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if CardioComm Solutions will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of OUGA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. CardioComm Solutions's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. CardioComm Solutions's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess CardioComm Solutions's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
CardioComm Solutions has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

OUGA Past Performance

  How has CardioComm Solutions performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare CardioComm Solutions's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • CardioComm Solutions does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare CardioComm Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare CardioComm Solutions's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
CardioComm Solutions's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from CardioComm Solutions Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:OUGA Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 0.95 -0.59 1.12 0.06
2019-06-30 0.99 -0.59 1.11 0.08
2019-03-31 0.98 -0.65 1.17 0.09
2018-12-31 1.08 -0.58 1.15 0.09
2018-09-30 1.18 -0.34 1.11 0.11
2018-06-30 1.26 -0.23 1.06 0.08
2018-03-31 1.58 -0.05 1.09 0.09
2017-12-31 1.74 0.04 1.21 0.09
2017-09-30 1.74 0.02 1.66 0.07
2017-06-30 1.78 0.02 1.57 0.08
2017-03-31 1.66 0.02 1.34 0.08
2016-12-31 1.56 -0.02 1.07 0.08
2016-09-30 1.56 -0.18 0.41 0.09
2016-06-30 1.49 -0.38 0.44 0.08
2016-03-31 1.51 -0.58 0.47 0.10
2015-12-31 1.73 -0.60 0.59 0.11
2015-09-30 1.89 -0.50 0.64 0.11
2015-06-30 1.70 -0.68 0.61 0.15
2015-03-31 1.58 -0.82 0.58 0.25
2014-12-31 1.50 -0.95 0.50 0.37
2014-09-30 1.09 -1.64 0.51 0.62
2014-06-30 1.45 -1.57 0.58 0.79
2014-03-31 1.59 -1.63 0.60 0.89
2013-12-31 1.70 -1.70 0.67 0.95
2013-09-30 1.88 -2.50 0.97 1.53
2013-06-30 1.54 -3.06 0.99 1.63
2013-03-31 1.52 -3.42 1.20 1.80

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if CardioComm Solutions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if CardioComm Solutions has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if CardioComm Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess CardioComm Solutions's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
CardioComm Solutions has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

OUGA Health

 How is CardioComm Solutions's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up CardioComm Solutions's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • CardioComm Solutions's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • CardioComm Solutions has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of CardioComm Solutions's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • CardioComm Solutions has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from CardioComm Solutions Company Filings, last reported 6 months ago.

DB:OUGA Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 -0.24 0.50 0.10
2019-06-30 -0.48 0.50 0.07
2019-03-31 -0.10 0.60 0.19
2018-12-31 -0.07 0.60 0.14
2018-09-30 0.14 0.60 0.24
2018-06-30 0.23 0.60 0.31
2018-03-31 0.42 0.60 0.20
2017-12-31 0.49 0.60 0.35
2017-09-30 0.45 0.60 0.34
2017-06-30 0.43 0.60 0.39
2017-03-31 0.10 0.63 0.07
2016-12-31 -0.01 0.60 0.21
2016-09-30 -0.57 0.94 0.09
2016-06-30 -0.72 0.96 0.01
2016-03-31 -0.70 0.96 0.04
2015-12-31 -0.69 1.01 0.10
2015-09-30 -0.57 1.04 0.10
2015-06-30 -0.59 1.09 0.06
2015-03-31 -0.49 0.97 0.07
2014-12-31 -0.60 0.98 0.17
2014-09-30 -0.59 0.99 0.03
2014-06-30 -0.45 0.98 0.17
2014-03-31 -0.15 0.94 0.40
2013-12-31 -0.34 0.84 0.10
2013-09-30 0.25 0.47 0.18
2013-06-30 0.34 0.27 0.29
2013-03-31 0.62 0.09 0.05
  • CardioComm Solutions has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if CardioComm Solutions's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • CardioComm Solutions has less than a year of cash runway based on current free cash flow.
  • CardioComm Solutions has less than a year of cash runway if free cash flow continues to reduce at historical rates of -34% each year.
X
Financial health checks
We assess CardioComm Solutions's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. CardioComm Solutions has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

OUGA Dividends

 What is CardioComm Solutions's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from CardioComm Solutions dividends.
If you bought €2,000 of CardioComm Solutions shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate CardioComm Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate CardioComm Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:OUGA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 1%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as CardioComm Solutions has not reported any payouts.
  • Unable to verify if CardioComm Solutions's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of CardioComm Solutions's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as CardioComm Solutions has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess CardioComm Solutions's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can CardioComm Solutions afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. CardioComm Solutions has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

OUGA Management

 What is the CEO of CardioComm Solutions's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Etienne Grima
COMPENSATION CA$195,034
TENURE AS CEO 9.9 years
CEO Bio

Mr. Etienne Grima, MSc, CHE has been the Chief Executive Officer of Cardiocomm Solutions Inc., since May 2010. Mr. Grima serves as Corporate Secretary of Cardiocomm Solutions Inc. since January 28, 2008. Mr. Grima served as the Chief Operating Officer and Chief Financial Officer of Canadian Heart Research Centre from January 2008 to May 2011. Mr. Grima served as the Chief Financial Officer of Cardiocomm Solutions Inc. since January 28, 2008 until May 2010. Mr. Grima has over 22 years of experience in basic and clinical research administration, business development and strengthening corporate performance. Prior to the CHRC, he managed the St. Michael's Hospital (SMH) Health Sciences Research Centre in Toronto. Etienne guided SMH to become the fastest growing University of Toronto affiliated research center between 1994 and 1997, acting as the signing officer on 350 externally funded clinical and basic research budgets and overseeing the design, construction and maintenance of 27,000 square feet of clinical and basic research laboratories. During his tenure, he developed a detailed understanding and methodology of the successful performance of clinical research within a hospital environment and became a member and Accredited Health Science Executive of the Canadian College of Health Service Executives. He has been a Director of Cardiocomm Solutions Inc. since November 29, 2006. Mr. Grima's educational background was rooted in his persistent interest in biology and he completed his academic career with an emphasis on human physiology, toxicology and zoology graduating from University of Toronto with high distinction in 1984. He completed his graduate studies in 1986 with a Masters degree from the Faculty of Medicine, Department of Physiology, Centre for Research in Neurodegenerative and served as a peer reviewer for research publications and grant applications.

CEO Compensation
  • Etienne's compensation has increased whilst company is loss making.
  • Etienne's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the CardioComm Solutions management team in years:

3.6
Average Tenure
  • The tenure for the CardioComm Solutions management team is about average.
Management Team

Etienne Grima

TITLE
CEO, Corporate Secretary & Director
COMPENSATION
CA$195K
TENURE
9.9 yrs

Anne Burpee

TITLE
Chief Financial Officer
COMPENSATION
CA$7K
TENURE
1.3 yrs

Simi Grosman

TITLE
Consultant & Director
COMPENSATION
CA$5K
TENURE
3.6 yrs
Board of Directors Tenure

Average tenure of the CardioComm Solutions board of directors in years:

3.6
Average Tenure
  • The tenure for the CardioComm Solutions board of directors is about average.
Board of Directors

Bob Caines

TITLE
Chairman
COMPENSATION
CA$10K
TENURE
3.4 yrs

Etienne Grima

TITLE
CEO, Corporate Secretary & Director
COMPENSATION
CA$195K
TENURE
13.3 yrs

Simi Grosman

TITLE
Consultant & Director
COMPENSATION
CA$5K
TENURE
9 yrs

David Newman

TITLE
Independent Director
COMPENSATION
CA$5K
TENURE
9.8 yrs

Robin Black

TITLE
Member of Advisory Board
TENURE
3.6 yrs

John Foote

TITLE
Independent Director
COMPENSATION
CA$5K
TENURE
2.4 yrs

Steve Benyo

TITLE
Independent Director
COMPENSATION
CA$7K
TENURE
2.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess CardioComm Solutions's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. CardioComm Solutions has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

OUGA News

Simply Wall St News

OUGA Company Info

Description

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company’s technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals, and call centers to access and manage patient information. The company’s software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a Web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service. Additionally, CardioComm Solutions, Inc. provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. The company was incorporated in 1989 and is headquartered in Toronto, Canada.

Details
Name: CardioComm Solutions, Inc.
OUGA
Exchange: DB
Founded: 1989
CA$2,267,534
141,489,754
Website: http://www.cardiocommsolutions.com
Address: CardioComm Solutions, Inc.
259 Yorkland Road,
Suite 200,
Toronto,
Ontario, M2J 0B5,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV EKG Common Shares TSX Venture Exchange CA CAD 06. Jul 1995
OTCPK EKGG.F Common Shares Pink Sheets LLC US USD 06. Jul 1995
DB OUGA Common Shares Deutsche Boerse AG DE EUR 06. Jul 1995
Number of employees
Current staff
Staff numbers
0
CardioComm Solutions employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/30 23:55
End of day share price update: 2020/03/30 00:00
Last earnings filing: 2019/11/29
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.